White Lighthouse Investment Management Inc. Boosts Stock Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

White Lighthouse Investment Management Inc. raised its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBBFree Report) by 2.8% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 12,762 shares of the financial services provider’s stock after buying an additional 350 shares during the period. White Lighthouse Investment Management Inc.’s holdings in iShares Biotechnology ETF were worth $1,734,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in the business. Moneta Group Investment Advisors LLC boosted its holdings in shares of iShares Biotechnology ETF by 131,598.4% during the fourth quarter. Moneta Group Investment Advisors LLC now owns 4,469,845 shares of the financial services provider’s stock worth $586,846,000 after purchasing an additional 4,466,451 shares during the period. JPMorgan Chase & Co. boosted its holdings in shares of iShares Biotechnology ETF by 159.9% during the first quarter. JPMorgan Chase & Co. now owns 1,966,359 shares of the financial services provider’s stock worth $253,975,000 after purchasing an additional 1,209,700 shares during the period. Goldman Sachs Group Inc. boosted its holdings in shares of iShares Biotechnology ETF by 49.9% during the first quarter. Goldman Sachs Group Inc. now owns 1,568,159 shares of the financial services provider’s stock worth $204,332,000 after purchasing an additional 521,820 shares during the period. Itau Unibanco Holding S.A. purchased a new stake in shares of iShares Biotechnology ETF during the third quarter worth about $48,242,000. Finally, Two Sigma Advisers LP boosted its holdings in shares of iShares Biotechnology ETF by 306.6% during the first quarter. Two Sigma Advisers LP now owns 210,599 shares of the financial services provider’s stock worth $27,201,000 after purchasing an additional 158,800 shares during the period. 62.45% of the stock is currently owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Price Performance

IBB stock traded down $0.04 during trading on Wednesday, reaching $133.85. The company had a trading volume of 812,294 shares, compared to its average volume of 1,837,087. iShares Biotechnology ETF has a 52 week low of $111.83 and a 52 week high of $141.16. The business has a 50 day moving average of $136.49 and a 200 day moving average of $129.02.

iShares Biotechnology ETF Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, March 27th. Investors of record on Friday, March 22nd were paid a $0.126 dividend. This represents a $0.50 dividend on an annualized basis and a yield of 0.38%. The ex-dividend date was Thursday, March 21st.

iShares Biotechnology ETF Profile

(Free Report)

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Featured Articles

Want to see what other hedge funds are holding IBB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares Biotechnology ETF (NASDAQ:IBBFree Report).

Institutional Ownership by Quarter for iShares Biotechnology ETF (NASDAQ:IBB)

Receive News & Ratings for iShares Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.